Literature DB >> 2310102

Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury.

N Gilliard1, P M Richman, T A Merritt, R G Spragg.   

Abstract

Administration of exogenous lung surfactant to infants with or at risk for respiratory distress syndrome has been demonstrated to improve gas exchange and survival; administration of surfactant to patients with the adult respiratory distress syndrome is currently undergoing clinical evaluation. Although it is currently assumed the optimal effect will occur when administered surfactant is distributed homogeneously throughout the lung, little is known of the influence of variables inherent in the administration procedure on subsequent distribution. To address this question, we studied the effect of the volume size in which the surfactant is suspended for instillation, and demonstrated a marked relationship in the normal rabbit lung between this volume and the subsequent homogeneity of surfactant distribution. In the rabbit lung that was acutely injured by oleic acid, this relationship was not evident. Concentration of administered surfactant was not demonstrated to be of major influence on its distribution after administration. Our results focus attention on the importance of parameters of the administration procedure, and also demonstrate the usefulness of the techniques used for determination of surfactant distribution.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2310102     DOI: 10.1164/ajrccm/141.3.743

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Three-dimensional model of surfactant replacement therapy.

Authors:  Marcel Filoche; Cheng-Feng Tai; James B Grotberg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

2.  Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS.

Authors:  Marla R Wolfson; Jichuan Wu; Terrence L Hubert; Timothy J Gregory; Jan Mazela; Thomas H Shaffer
Journal:  Pediatr Res       Date:  2012-07-20       Impact factor: 3.756

3.  Chest position and pulmonary deposition of surfactant in surfactant depleted rabbits.

Authors:  R Broadbent; T F Fok; M Dolovich; J Watts; G Coates; B Bowen; H Kirpalani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

Review 4.  [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].

Authors:  S Lauer; L G Fischer; H D Stubbe; H Van Aken; M Westphal
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

Review 5.  The fate of exogenous surfactant in neonates with respiratory distress syndrome.

Authors:  M Hallman; T A Merritt; K Bry
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

6.  Acute hemorrhagic respiratory failure caused by Wegener's granulomatosis successfully treated by bronchoalveolar lavage with diluted surfactant.

Authors:  Michael M Hermon; Johann Golej; Wolfgang Emminger; Stefan Puig; Zsolt Szepfalusi; Gerhard Trittenwein
Journal:  Wien Klin Wochenschr       Date:  2003-11-28       Impact factor: 1.704

7.  Surfactant delivery in rat lungs: Comparing 3D geometrical simulation model with experimental instillation.

Authors:  Alireza Kazemi; Bruno Louis; Daniel Isabey; Gary F Nieman; Louis A Gatto; Joshua Satalin; Sarah Baker; James B Grotberg; Marcel Filoche
Journal:  PLoS Comput Biol       Date:  2019-10-17       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.